ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,074Medicare Part D Prescriptions Filled, Including Refills

Rank: 198 out of 1692

$551K Total Retail Price of All Prescriptions

Rank: 203 out of 1692

401 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 8,075 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 646 522 1 1
AMLODIPINE BESYLATE 467 423 2 3
FUROSEMIDE 324 250 3 7
LEVOTHYROXINE SODIUM 320 293 4 4
OMEPRAZOLE 293 241 5 5
METFORMIN HCL 238 201 6 8
LISINOPRIL 222 188 7 2
HYDROCHLOROTHIAZIDE 213 162 8 9
ZOLPIDEM TARTRATE 195 160 9 23
DICLOFENAC SODIUM 185 156 10 75
LOSARTAN POTASSIUM 180 146 11 17
METOPROLOL TARTRATE 148 118 12 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 109 13 19
METOPROLOL SUCCINATE 137 129 14 18
CARVEDILOL 134 100 15 24
ATORVASTATIN CALCIUM 131 116 16 11
ADVAIR DISKUS 128 87 17 45
TAMSULOSIN HCL 125 109 18 31
ALLOPURINOL 124 103 19 30
FLUTICASONE PROPIONATE 119 95 20 27
GABAPENTIN 117 95 21 13
LOSARTAN-HYDROCHLOROTHIAZIDE 116 99 22 38
PANTOPRAZOLE SODIUM 111 89 23 39
GLIMEPIRIDE 108 92 24 32
HYDROCODONE-ACETAMINOPHEN 106 71 S3 25 6
CLONIDINE HCL 101 86 26 46
TRAMADOL HCL 95 86 27 16
CLOPIDOGREL 94 74 28 43
PREDNISONE 87 60 29 35
CRESTOR 87 68 29 26
KLOR-CON M20 86 73 31 48
SERTRALINE HCL 85 69 32 22
PROAIR HFA 83 43 33 40
AMITRIPTYLINE HCL 77 64 R 34 58
METFORMIN HCL ER 71 49 35 49
PRAVASTATIN SODIUM 70 54 36 12
LOVASTATIN 67 50 37 37
JANUVIA 67 53 37 72
ISOSORBIDE MONONITRATE ER 66 61 39 55
INSULIN SYRINGE 64 63 40 93
NEXIUM 62 23 41 25
SINGULAIR 62 47 41 79
BENAZEPRIL HCL 61 50 43 69
AZITHROMYCIN 60 36 44 34
PLAVIX 59 50 45 66
LANSOPRAZOLE 58 44 46 133
SPIRIVA 56 50 47 44
FENOFIBRATE 55 55 48 63
TRAMADOL HCL-ACETAMINOPHEN 55 37 48 215
NABUMETONE 54 40 50 158
WARFARIN SODIUM 53 53 51 14
SPIRONOLACTONE 51 47 52 74
VERAPAMIL ER 50 49 53 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.